Post COVID-Vaccine Cerebritis: A Case Report

Authors

  • Farah Sadiq Medical Unit 3, Lahore General Hospital, Lahore, Punjab, Pakistan
  • Muhammad Huzaifa Ameer Medical Unit 1, Lahore General Hospital, Lahore, Punjab, Pakistan
  • Talha Bin Sajid Medical Unit 3, Lahore General Hospital, Lahore, Punjab, Pakistan
  • Asif Niazi Medical Unit 3, Lahore General Hospital, Lahore, Punjab, Pakistan

DOI:

https://doi.org/10.51846/jucmd.v4i1.3401

Keywords:

Cerebritis, COVID-19, Sinopharm Vaccine

Abstract

We are reporting here a case of a 33-year-old male who presented to the Emergency Department at Lahore General Hospital in June, 2021, with a short history of fever and generalised tonic-clonic seizures. The symptoms started one day after getting the first dose of Sinopharm vaccine. He was managed initially on the line of refractory status epilepticus in the ICU and was given empirical cover for meningoencephalitis. CSF analysis report came out normal. MRI of the brain showed left frontal lobe cerebritis. Fits and fever settled and the patient fully recovered on the third day of admission. There are very few reported neurological complications of Covid-19 vaccination. One of the rare complications which we have seen with the sinopharm vaccine is cerebritis. This case raises awareness among physicians and contributes to the existing literature so that more vigilance is done while administrating COVID-19 vaccines.

 

Downloads

Published

03-11-2024

How to Cite

1.
Sadiq F, Muhammad Huzaifa Ameer, Talha Bin Sajid, Asif Niazi. Post COVID-Vaccine Cerebritis: A Case Report . J Univ Coll Med Dent. [Internet]. 2024 Nov. 3 [cited 2025 Jul. 5];4(1):94-6. Available from: https://journals.uol.edu.pk/jucmd/article/view/3401

Issue

Volume 4 Issue 1

Section

Case Report / Case Series

License

Copyright (c) 2024 Farah Sadiq, Muhammad Huzaifa Ameer Ameer, Talha Bin Sajid bin Sajid, Asif Niazi Niazi

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository, in a journal or publish it in a book), with an acknowledgment of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process.